Anti-diabetic drugs

Metformin, sold under the brand name Glucophage, among others, is the main first-line medication for the treatment of type2 diabetes, particularly in people who are overweight. It is also used in the treatment of polycystic ovary syndrome, and is sometimes used as an off-label adjunct to lessen the risk of metabolic syndrome in people who take antipsychotic medication. It has been shown to inhibit inflammation, and is not associated with weight gain. Metformin is taken by mouth.

substances which lower blood glucose levels

peptide in Homo sapiens

class of pharmaceutical drugs

agonist of the GLP-1 receptor used in the treatment of type 2 diabetes and obesity

Teplizumab, sold under the brand name Tzield among others, is an anti-CD3 humanized monoclonal antibody that is the first approved treatment indicated to delay the onset of stage 3 type1 diabetes in people with stage 2 type1 diabetes.

Imeglimin (EMD- 387008,PXL- 008,RVT-1501, brand name Twymeeg) is an oral anti-diabetic medication. It was approved for use in Japan in June 2021.

Dasiglucagon, sold under the brand name Zegalogue, is a medication used to treat severe hypoglycemia in people with diabetes.